|Year : 2019 | Volume
| Issue : 4 | Page : 235-239
Retinopathy of Prematurity Incidence and Risk Factors in a Tertiary Hospital in Riyadh, Saudi Arabia
Bader Al-Qahtani1, Mohammed Al-Otaibi1, Khaled Alabdulajabbar1, Nawaf Bin Selayem1, Waleed Alshehri1, Aamir Omair1, Saif Alsaif2
1 Department of Ophthalmology, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
2 Department of Neonatology, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia
|Date of Submission||07-Nov-2018|
|Date of Acceptance||20-Jan-2020|
|Date of Web Publication||29-Jan-2020|
Dr. Bader Al-Qahtani
College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, P. O. Box 22490, Mail Code: 3130, Riyadh, 11426
Source of Support: None, Conflict of Interest: None
| Abstract|| |
PURPOSE: The purpose of the study was to determine the incidence of retinopathy of prematurity (ROP) in preterm infants in the neonatal intensive care unit (NICU), to identify the risk factors that predispose to ROP, and to assess the outcome of these infants.
MATERIALS AND METHODS: This was a retrospective cohort study on premature infants with a birth weight (BW) of <1501 g or gestational age (GA) of <32 weeks. These infants were admitted to the NICU at a tertiary hospital in Riyadh, Saudi Arabia, from January 2010 to December 2014.
RESULTS: Five hundred and ninety-three infants were included; data were available for 581 infants. Of them, 224 infants (38.6%) had ROP. Of these, 22 infants (10.4%) had stage 3 ROP. The mean BW of infants with ROP was 938.4 ± 257.9 g, and the mean GA at birth was 27 ± 2.4 weeks. A significant relationship with a P <0.05 was found between the occurrence of ROP and small GA at birth, low BW, low APGAR score at 1 min, and long duration of receiving oxygen (O2) therapy. Based on charts review, none of the infants had blindness.
CONCLUSION: The incidence of ROP in our study falls in the range of incidence in developing countries. The low BW and small GA were the most significant risk factors. Furthermore, it is also recommended to control the amount and duration of O2therapy to as little as needed.
Keywords: Incidence, prematurity, retinopathy, risk factor
|How to cite this article:|
Al-Qahtani B, Al-Otaibi M, Alabdulajabbar K, Selayem NB, Alshehri W, Omair A, Alsaif S. Retinopathy of Prematurity Incidence and Risk Factors in a Tertiary Hospital in Riyadh, Saudi Arabia. Middle East Afr J Ophthalmol 2019;26:235-9
|How to cite this URL:|
Al-Qahtani B, Al-Otaibi M, Alabdulajabbar K, Selayem NB, Alshehri W, Omair A, Alsaif S. Retinopathy of Prematurity Incidence and Risk Factors in a Tertiary Hospital in Riyadh, Saudi Arabia. Middle East Afr J Ophthalmol [serial online] 2019 [cited 2020 Apr 9];26:235-9. Available from: http://www.meajo.org/text.asp?2019/26/4/235/277261
| Introduction|| |
Retinopathy of prematurity (ROP) can be considered as one of the most common causes of blindness in children. It is defined as “a potentially blinding eye disorder that primarily affects premature infants weighing about 1250 g or less that are born before 31 weeks of gestation.” ROP was diagnosed for the first time in 1942 by Terry, so it was previously called “Terry syndrome.”. The development of ROP is due to the formation of immature vasculature in the retina of premature infants which might lead to retinal detachment and blindness. There are two phases of how these immature vessels formed. First, a hyperoxic phase causes constriction of the retinal vessels and ischemia. Second, this ischemia might lead to angiogenic factor production by the mesenchymal spindle cells and the formation of immature new vessels subsequently., The International Classification of ROP was formed in 1984. It classifies the ROP according to the location of the disease into zones of the retina (1, 2, and 3), the extent of the disease based on the clock hours (1–12), and the severity of the disease into different stages (0–5).
Few studies have been conducted in the Kingdom of Saudi Arabia; a retrospective study was conducted by Binkhathlan et al. in 2008, in which 174 infants were included from the neonatal intensive care unit (NICU) in Riyadh. The incidence of ROP in their study was 56%; 15% of those patients had Stage 3 ROP. The mean gestational age (GA) was 30 weeks for the ROP-positive group. In another study carried out in 2003 at a University Hospital in Riyadh, it included 195 consecutive preterm infants in the NICU during the period from 1995 to 1998. The study found that the overall incidence of ROP was 37.4%. A percentage of 26% of these children who were diagnosed with ROP reached threshold ROP and needed laser treatment or cryotherapy that induced regression in all of the patients.
Risk factors for ROP have been the main concern in many previous studies. Most of the suggested risk factors include preterm delivery, low birth weight (BW), and excessive oxygen (O2) supplementation to the baby that might affect the immature retina. Other risk factors might occur in the postnatal period of the baby's life. These include neonatal bacteremia (sepsis), anemia, hyperglycemia, and chronic lung disease., Shastry et al. suggested that genetic predisposition is an important risk factor of ROP. Early diagnosis and screening measures are very important aspects of treating ROP since early intervention can improve visual outcomes. Detailed fundus examination for all babies who have a recognized risk factor for ROP is the mainstay of screening. Failure of diagnosis and proper management can result in loss of vision, amblyopia, strabismus, and retinal detachment.
The purpose of this study was to assess the incidence of ROP, its risk factors, complications, and the effects of comorbidity on the outcome of the treatment. The findings of this study will provide a good update to local studies and help in planning better approaches to improve the management of the ROP.
| Materials and Methods|| |
This was a hospital-based, retrospective cohort study conducted in the neonatology department at a tertiary hospital in King Abdulaziz Medical City, Riyadh, Saudi Arabia. It is a 1000-bed specialized health-care institution that covers a wide range of secondary and tertiary care specialties. Neonatology division is one of the biggest neonatology divisions in the whole kingdom, with the number of deliveries reaching 9,000 live births per year. It encompasses a Level III B NICU, with 40-ventilated NICU bed capacities, aside from the 70 beds in the special care nurseries.
Saudi and non-Saudi male and female babies who were admitted to the NICU between January 1, 2010, and December 30, 2014, were studied. We restricted our sample for patients who have had BW <1500 g or born at <32 weeks GA. Furthermore, all infants who received >49 days of continuous O2 therapy were included in the study. Infants with major congenital anomalies and those who died before the discharge from NICU were excluded from the study. Data that were collected for the babies included the date of birth, sex, GA at birth, and BW. We also recorded all relevant information including concomitant conditions such as interventricular hemorrhage, sepsis, necrotizing enterocolitis (NEC), duration of O2 therapy and mechanical ventilation, and pre- and postnatal medications. Diagnosis, stage, zone, and mode of treatment of ROP were also documented.
All data variables were managed and analyzed by IBM SPSS software. Continuous variables such as age and BW were expressed as mean ± standard deviation. Categorical variables such as gender and the comorbidities were presented as frequencies and percentages. To evaluate the risk factors, the Chi-square test or Fisher's exact test has been applied. P < 0.05 was considered to show a significant difference.
This study was performed following the ethical standards of the 1964 Helsinki Declaration, and ethical approval was obtained from the Institutional Research Board at King Abdulaziz Medical City, Riyadh, Saudi Arabia.
| Results|| |
A total of 3146 infants were admitted to the NICU during the study period. A number of 593 infants met our inclusion criteria. Among which, 272 infants were males (45.9%). Of the 593 infants, there were 197 (33.2%) normal spontaneous vaginal delivery, 43 (7.3%) assisted delivery, 345 (58.2%) were Cesarean Section, and 8 (1.3%) were not documented. The mean BW was 1118 ± 276.6 g (range: 430–2280 g) and the mean GA at birth was 28.8 ± 2.8 weeks (range: 22–39 weeks). Of 585 infants, there were 367 (61.9%) singletons, while 218 (38.1%) were the results of multiple pregnancies.
ROP was diagnosed in 224 (38.6%) of the 581 babies who were evaluated for ROP, of these, 212 were staged for ROP and 22 (10.4%) had Stage 3, i.e., severe disease [Figure 1]. The mean GA of infants with ROP was 27 ± 2.4 weeks, and the mean BW was 938.4 ± 257.9 g (median = 907.5, range = 430–2280). Both eyes were affected by ROP in 131 infants (60%), isolated left eyes were affected in 42 (19%) infants, and isolated right eyes were affected in 45 (21%) infants. Three infants (1.5%) developed threshold ROP requiring treatment, i.e., Stage 3 in Zone 1 or 2 with plus disease and at least 5 contiguous or 8 cumulative clock hours of involvement. The comparison of the BW and GA of infants with and without ROP is shown in [Table 1] and [Table 2], respectively. It was found that infants with ROP were more likely to have BWs <1000 g and GA <28 weeks as compared to infants without ROP (P<0.001).
|Figure 1:Distribution of infants' admissions to NICU. *No ROP includes 12 cases that had missing data for ROP. NICU; Neonatal intensive care unit, ROP; Retinopathy of prematurity|
Click here to view
The significant risk factors for ROP (P<0.05) included GA at birth (P<0.001), BW (P<0.001), APGAR score at 1 min after birth (P = 0.003), duration of receiving O2 therapy (P<0.0001), and duration of mechanical ventilation (P<0.0001). The insignificant risk factors for ROP (P ≥ 0.05) included the age of the mother at the time of delivery (P = 0.704), how many babies the mother was pregnant with (P = 0.051), and the APGAR scores at 5 min and 10 min (P = 0.190) and (P = 0.280), respectively.
All of the risk factors were included in multiple backward logistic regression analysis. BW < 1500 g at birth was found to be the most significant risk factor for ROP, (odds ratio [OR] = 11.6, 95% confidence interval [CI] from 1.07 to 126.02, P = 0.04), followed by GA at birth < 32 weeks (OR = 3.35, 95% CI from 1.22 to 9.16, P = 0.02). Other risk factors are shown in [Table 3] with OR and P value.
|Table 3: Risk factors odds ratio and its respective confidence intervals|
Click here to view
Among those 224 infants with ROP, three infants had a laser treatment and 12 had anti-vascular endothelial growth factor (VEGF). The most commonly used anti-VEGF treatment for ROP in our center was ranibizumab (Lucentis). Based on the chart review after at least 3 months of discharge, no one of those infants had blindness.
During the review of charts, five patients have been found to have ROP with a GA of more than 32 weeks. One of them had 35, two of them had 34, and two had 33 weeks. In addition, a number of two patients have been found to have ROP with a BW of more than 1500 g.
| Discussion|| |
In our tertiary hospital, we follow the Ministry of Health Guidelines for ROP screening. These guidelines identify premature infants with GA at birth of <32 weeks and BW of <1500 g as potentials at risk of ROP. Moreover, those patients who had other comorbidities, for example, O2 therapy, surfactant use, septicemia, and NEC, were of special attention. A full dilated fundus examination with the use of lid speculum and scleral depressor has been done for every premature infant at the postmenstrual age of 31 weeks or 4–6 weeks chronological (postnatal) age whichever is later. Follow-up examinations were recommended by the examining ophthalmologist on the basis of retinal findings classified according to the International Classification.
The universal reported incidence of ROP among infants with risk ranges between 29 and 68%.,,,, In this study, 37.8% of the patients were diagnosed with ROP, and this is similar to what has been reported by Al-Amro et al. in 2003 but much lesser than the percentage found in Binkhathlan et al. study in 2008, due to the larger sample size, longer review period (2010–2014), and the concordance with one of the local studies; we believe that our results are targeting the correct incidence in the Kingdom of Saudi Arabia.
Among the study population, the difference in the proportion of males and females who had ROP in the study period was statistically insignificant. This is concordant with a study that has been done in Iran by Feghhi et al. in 2012, with the results showing insignificant male/female ratio. Furthermore, the number of babies during the pregnancy either singleton or multiple has shown to be insignificant in this study, which is also concordant with the previous Iranian study.
The occurrence of some risk factors for ROP has been found to be significant among most of the studies including this study. Those factors included small GA at birth, low BW, low APGAR score at 1 min after birth, and long duration of receiving O2 therapy.,,,,,,,, As our NICU follows a conservative O2 saturation policy, i.e., 88%–92%, the ROP incidence was found to be related to the duration of O2 therapy more than the amount.
During the review of charts, five patients have been found to have ROP with GA more than 32 weeks. One of them had 35, two of them had 34, and two had 33 weeks. In addition, a number of two patients have been found to have ROP with BW more than 1500 g. A similar observation has been noted by Binkhathlan et al. in 2008. These findings indicate that the current screening criteria in Saudi Arabia might need some modifications to involve such cases by widening the inclusion criteria to include infants with GA more than 32 weeks and those born with BW more than 1500 g.
Since the advances in treating ROP with laser and more recently with anti-VEGF for threshold ROP, a good prognosis is expected. Moreover, while the blindness caused by ROP is a serious issue and at least 50,000 infants are blind from ROP globally, none of the patients with ROP ended up with blindness in this study. We believe that careful screening and extensive proper management are good measures for those types of patients.
This study had some avoidable limitations. In addition, being a retrospective study with all the known limitations of such study design, all the patients were from only one hospital and with a relatively short follow-up duration of time.
| Conclusion|| |
ROP is one of the major diseases affecting premature infants. The incidence of ROP in our study is comparable to other local studies and falls in the range of disease incidence in developing countries. While the low BW and small GA were the most significant risk factors, the screening criteria of ROP should be broadened at least to include those infants with GAs between 32 and 35 weeks. Furthermore, it is also recommended to control the amount and duration of O2 therapy to as little as needed. Although blindness is well-known consequence of ROP, it has not been encountered in our study population.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Gilbert C. Retinopathy of prematurity: A global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev 2008;84:77-82.
National Eye Institute. Facts about Retinopathy of Prematurity. National Institutes of Health; 2014. Available from: http://https://nei.nih.gov/health/rop
. [Last accessed on 2014 Nov 22].
Chen J, Stahl A, Hellstrom A, Smith LE. Current update on retinopathy of prematurity: Screening and treatment. Curr Opin Pediatr 2011;23:173-8.
Smith LE. Pathogenesis of retinopathy of prematurity. Semin Neonatol 2003;8:469-73.
Heidary G, Vanderveen D, Smith LE. Retinopathy of prematurity: Current concepts in molecular pathogenesis. Semin Ophthalmol 2009;24:77-81.
International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 2005;123:991-9.
Binkhathlan AA, Almahmoud LA, Saleh MJ, Srungeri S. Retinopathy of prematurity in Saudi Arabia: Incidence, risk factors, and the applicability of current screening criteria. Br J Ophthalmol 2008;92:167-9.
Al-Amro SA, Al-Kharfi TM, Thabit AA, Al-Mofada SM. Retinopathy of prematurity at a University Hospital in Riyadh, Saudi Arabia. Saudi Med J 2003;24:720-4.
SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network, Carlo WA, Finer NN, Walsh MC, Rich W, Gantz MG, et al
. Target ranges of oxygen saturation in extremely preterm infants. N
Engl J Med 2010;362:1959-69.
Tolsma KW, Allred EN, Chen ML, Duker J, Leviton A, Dammann O. Neonatal bacteremia and retinopathy of prematurity: the ELGAN study. Arch Ophthalmol 2011;129:1555-63.
Ertl T, Gyarmati J, Gaál V, Szabó I. Relationship between hyperglycemia and retinopathy of prematurity in very low birth weight infants. Biol Neonate 2006;89:56-9.
Shastry BS. Genetic susceptibility to advanced retinopathy of prematurity (ROP). J Biomed Sci 2010;17:69.
Fierson WM; American Academy of Pediatrics Section on Ophthalmology, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus, American Association of Certified Orthoptists. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2013;131:189-95.
Shah VA, Yeo CL, Ling YL, Ho LY. Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore. Ann Acad Med Singapore 2005;34:169-78.
Isaza G, Arora S, Bal M, Chaudhary V. Incidence of retinopathy of prematurity and risk factors among premature infants at a neonatal intensive care unit in Canada. J Pediatr Ophthalmol Strabismus 2013;50:27-32.
Good WV, Hardy RJ, Dobson V, Palmer EA, Phelps DL, Quintos M, et al
. The incidence and course of retinopathy of prematurity: Findings from the early treatment for retinopathy of prematurity study. Pediatrics 2005;116:15-23.
Feghhi M, Altayeb SM, Haghi F, Kasiri A, Farahi F, Dehdashtyan M, et al
. Incidence of retinopathy of prematurity and risk factors in the South-Western region of Iran. Middle East Afr J Ophthalmol 2012;19:101-6.
] [Full text]
Wheatley CM, Dickinson JL, Mackey DA, Craig JE, Sale MM. Retinopathy of prematurity: Recent advances in our understanding. Arch Dis Child Fetal Neonatal Ed 2002;87:F78-82.
[Table 1], [Table 2], [Table 3]